You are here: Industry Insights > GlobalData

News List

E-pharma set to revolutionise drug market access in India: GlobalData expresspharma
September 17, 2020
E-pharma companies will offer competitive pricing and access to quality medicines even in remote places along with the ease of consultation.
Sanofi impacted by disrupted clinical trials and lagging vaccine development due to COVID-19: GlobalData expresspharma
September 07, 2020
Six of Sanofi’s clinical trials, which were being conducted in 31 countries, have been disrupted, which might impact the company's regulatory decisions.
67 per cent experts to use decentralised clinical trials in near future due to COVID-19: GlobalData expresspharma
September 02, 2020
Majority of respondents also consider the cost of decentralised clinical trials to be lower than that of traditional trials.
Gilead, AstraZeneca and Pfizer may be winners in race for COVID-19 therapeutics and vaccines: GlobalData expresspharma
August 31, 2020
More than 1,200 therapeutics and vaccines have entered the research and development (R&D) pipeline since January 2020, according to GlobalData, and that number grows every week.
Markets for GvHD in five APAC markets to grow at 8.2 per cent CAGR in 10 years: GlobalData expresspharma
August 28, 2020
The impact of approved therapies replacing generic off-label treatments will be the main driver of growth in the 5GM GvHD market.
India’s proposed new agile pharma regulations will benefit innovator companies: GlobalData expresspharma
August 28, 2020
This could mean accelerated access of multiple novel therapies and vaccines for Indian patients.
COVID-19 vaccines need novel approaches to ensure best balance of safety and efficacy: GlobalData expresspharma
August 27, 2020
AstraZeneca’s AZD-1222 and Moderna’s mRNA-1273 are currently the most promising vaccine candidates, it states.
AstraZeneca’s COVID-19 vaccine data may fall short of desirable protection results: GlobalData expresspharma
August 26, 2020
The ongoing early study only requires 30 COVID-19 cases to detect vaccine efficacy, which is much too small to be sure of protection and would only be suitable to support other larger trials, it states.
AI accelerates drug repurposing to find potential COVID-19 therapies: GlobalData expresspharma
August 19, 2020
AI start-ups are helping pharma companies to digitally bridge the gap between thousands of repurposed drug molecules, clinical trials and final drug authorization.
Indian CMO market hotbed for private equity investment, says report europeanpharmaceuticalreview
August 18, 2020
A report suggests that India’s CMO market has recently attracted investment from global private equity firms due to favourable government policies.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page